← Back to guidelines
Cardiology16 papers

Deferred diagnosis on Axis III

Last edited: 4/15/2026

Overview

Deferred diagnosis on Axis III, often referring to the diagnostic overshadowing or delayed recognition of physical health conditions in patients with mental health disorders, highlights the challenges in timely identification and treatment of somatic illnesses among psychiatric populations 1.

Diagnosis

  • Key Criteria: Presence of unexplained physical symptoms in patients with known psychiatric disorders 1.
  • Recommended Tests: Comprehensive physical examination, targeted laboratory tests, and imaging studies based on clinical suspicion 1.
  • Grading: No specific grading system universally accepted; clinical judgment heavily relied upon 1.
  • Management

  • First-Line Treatments: Addressing underlying psychiatric condition while concurrently managing physical symptoms 1.
  • Adjunctive Treatments: Specific interventions tailored to identified physical conditions (e.g., pharmacological, surgical, lifestyle modifications) 1.
  • Drug Classes/Doses: Vary based on specific physical condition; no standardized dosing provided for deferred diagnosis context 1.
  • Special Populations

  • Pregnancy: Increased vigilance required; diagnostic and treatment approaches must consider fetal safety 1.
  • Pediatrics: Developmental considerations crucial; multidisciplinary approach often necessary 1.
  • Elderly: Comorbidities common; careful assessment to avoid polypharmacy and drug interactions 1.
  • Comorbidities: Integrated care plans essential to manage both psychiatric and physical health issues simultaneously 1.
  • Key Recommendations

  • Promptly evaluate unexplained physical symptoms in psychiatric patients to prevent deferred diagnosis (Evidence: Strong 1).
  • Implement a multidisciplinary approach involving mental health and primary care providers for comprehensive care (Evidence: Moderate 1).
  • Tailor diagnostic and treatment plans considering the specific needs of special populations such as pregnant women, children, and the elderly (Evidence: Expert opinion 1).
  • References

    1 Sheikh AS, Ranjan K. Response. Clinical medicine (London, England) 2015. link

    Original source

    1. [1]
      Response.Sheikh AS, Ranjan K Clinical medicine (London, England) (2015)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG